S. Muoio & Co’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

S. Muoio & Co’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,000	Closed	-$753K	–	110
2021 Q1	$753K	Buy	+20,000	New	+$499K	0.81%	44

S. Muoio & Co's FPRX Position: Q2 2021 in Review

S. Muoio & Co sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 20,000 shares — an estimated $753K sold.

S. Muoio & Co first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $753K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

S. Muoio & Co reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
S. Muoio & Co sold 20,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $753K.
S. Muoio & Co first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
S. Muoio & Co's Five Prime Therapeutics, Inc. position peaked at $753K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on S. Muoio & Co's 13F filing for Q2 2021, filed 16 Aug 2021.